Theirs is ambulatory, i.e. for people to wear in their daily lives (mostly T1 and insulin-dependent T2). We're targeting a market that currently doesn't exist -- hospitalized patients, specifically people in critical care and people with diabetes on the general care floors. Similar terminology but very different markets!
Their latest AID (automated insulin delivery) system is killer, btw, some of the best results I've ever seen for ambulatory!